Australian Clinical Labs Ltd 2022 AR2
The report highlights Australian Clinical Labs' (ACL) strong financial and operational performance for the fiscal year ended June 30, 2022, marking its first full year as a publicly listed company. Key achievements include the successful acquisition and integration of Medlab Pathology, expanding ACL's national footprint across mainland Australia. On the ESG front, the company completed its first Scope 1 and Scope 2 greenhouse gas emissions audit to establish a baseline for future reduction targets. Additionally, ACL implemented sustainability initiatives such as hybrid courier vehicle pilots, smart metering, and digital paperless workflows to reduce its environmental impact.
Company: Australian Clinical Labs Ltd
Sector: Health Care
Country: Australia
Year: 2022
Type: AR2
Pages: 124
Back to company
Australian Clinical Labs Ltd
Annual Report
The report highlights Australian Clinical Labs' (ACL) strong financial and operational performance for the fiscal year ended June 30, 2022, marking its first full year as a publicly listed company. Key achievements include the successful acquisition and integration of Medlab Pathology, expanding ACL's national footprint across mainland Australia. On the ESG front, the company completed its first Scope 1 and Scope 2 greenhouse gas emissions audit to establish a baseline for future reduction targets. Additionally, ACL implemented sustainability initiatives such as hybrid courier vehicle pilots, smart metering, and digital paperless workflows to reduce its environmental impact.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jul 1, 2021 - Jun 30, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees